Correlation Between Genmab AS and Per Aarsleff

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Per Aarsleff at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Per Aarsleff into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Per Aarsleff Holding, you can compare the effects of market volatilities on Genmab AS and Per Aarsleff and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Per Aarsleff. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Per Aarsleff.

Diversification Opportunities for Genmab AS and Per Aarsleff

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Genmab and Per is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Per Aarsleff Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Per Aarsleff Holding and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Per Aarsleff. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Per Aarsleff Holding has no effect on the direction of Genmab AS i.e., Genmab AS and Per Aarsleff go up and down completely randomly.

Pair Corralation between Genmab AS and Per Aarsleff

Assuming the 90 days trading horizon Genmab AS is expected to generate 1.02 times more return on investment than Per Aarsleff. However, Genmab AS is 1.02 times more volatile than Per Aarsleff Holding. It trades about 0.04 of its potential returns per unit of risk. Per Aarsleff Holding is currently generating about 0.01 per unit of risk. If you would invest  155,150  in Genmab AS on December 2, 2024 and sell it today you would earn a total of  5,700  from holding Genmab AS or generate 3.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Per Aarsleff Holding

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Per Aarsleff Holding 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Per Aarsleff Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Per Aarsleff is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Genmab AS and Per Aarsleff Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Per Aarsleff

The main advantage of trading using opposite Genmab AS and Per Aarsleff positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Per Aarsleff can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Per Aarsleff will offset losses from the drop in Per Aarsleff's long position.
The idea behind Genmab AS and Per Aarsleff Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments